VEGFA and myocardial ischemia: A meta-analysis revealed that VEGF signaling pathway inhibitors significantly raise the odds of hypertension, cardiac ischemia, arterial thromboembolism, and cardiac dysfunction by 5.3, 2.8, 1.5, and 1.4 times, respectively.